Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering miR ‐194‐5p and elevating HK2 expression
Clinical and Experimental Pharmacology and Physiology · 2023
DOI: 10.1111/1440-1681.13763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2023. Verfasst von Dawei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Fourth Medical Center of PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Osteosarcoma, MicroRNAs, Bone Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Osteosarcoma (OS) is the most common bone tumour with a high risk of metastatic progression and recurrence after treatment. Circular RNA hsa_circ_0000591 (circ_0000591) plays a compelling role in OS aggressiveness. However, the function and regulatory mechanism of circ_0000591 need to be further elucidated. As a subject of this study, a differential circRNA circ_0000591 was screened by circRNA microarray expression profiling (GSE96964). Expression changes of circ_0000591 were detected using real‐time quantitative polymerase chain reaction (RT‐qPCR). Effects of circ_0000591 silencing on OS cell viability, proliferation, colony formation, apoptosis, invasion, and glycolysis were determined via functional experiments. The mechanism by which circ_0000591 functions as a molecular sponge for miRNAs was predicted using bioinformatics analysis and validated using dual‐luciferase reporter and RNA pull‐down assays. Xenograft assay was done to validate the function of circ_0000591. Circ_0000591 was strongly expressed in OS samples and cells. Silencing of circ_0000591 lessened cell viability, repressed cell proliferation, invasion, glycolysis, and promoted cell apoptosis. Importantly, circ_0000591 regulated HK2 expression by serving as a miR‐194‐5p molecular sponge. MiR‐194‐5p silencing impaired circ_0000591 downregulation‐mediated suppression of OS cell malignancy and glycolysis. HK2 overexpression weakened the inhibiting impacts of miR‐194‐5p on OS cell malignancy and glycolysis. Also, circ_0000591 silencing decreased xenograft tumour growth in vivo. Circ_0000591 drove OS glycolysis and growth by upregulating HK2 by sequestering miR‐194‐5p. The study highlighted the tumour‐promoting function of circ_0000591 in OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Fourth Medical Center of PLA General Hospital, Beijing, China.
- Sanya Central Hospital (Hainan Third People's Hospital), Sanya, China.
Zitieren
APA
Wang, D., Wang, Y., Wang, H., Yang, Y., Li, L., Liu, Y., & Yin, X. (2023). Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering miR ‐194‐5p and elevating HK2 expression. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.13763
Vancouver
Wang D, Wang Y, Wang H, Yang Y, Li L, Liu Y, et al. Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering miR ‐194‐5p and elevating HK2 expression. Clinical and Experimental Pharmacology and Physiology. 2023. doi:10.1111/1440-1681.13763
BibTeX
@article{Wang2023,
author = {Wang, Dawei and Wang, Yang and Wang, Huadong and Yang, Yafeng and Li, Li and Liu, Yihao and Yin, Xin},
title = {Hsa_circ_0000591 drives osteosarcoma glycolysis and progression by sequestering miR ‐194‐5p and elevating HK2 expression},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2023},
doi = {10.1111/1440-1681.13763}
}
EUVIMED